Clexane®

Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.

Praluent®

Alirocumab is a fully human IgG1 monoclonal antibody. It’s a PCSK9 inhibitor that is administered subcutaneously.
 

Plavix®

Clopidogrel is an inhibitor of platelet aggregation administered orally and indicated for Secondary prevention of atherothrombotic events.
 

Soliqua®

Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.
 

Toujeo®

Insulin Glargine 300, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 6 years.
 

Apidra®

Insulin Glulisine, a fast-acting insulin administered subcutaneously used for treatment of adults, adolescents and children 6 years or older, with diabetes mellitus, where treatment with insulin is required.

Dupixent®

Is a fully human monoclonal antibody with multiple indications in different therapeutic areas.

Lantus®

Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.

Aubagio®

AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)
   

Lemtrada®

Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).

Amaryl®

Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.

▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.